Skip to Main Content
YSM Home

INFORMATION FOR

Interventional Radiology

General Information

P.O. Box 208042, South Pavilion 2-213
New Haven, CT 06520-8042
Admin Assistant,Lori Raccio
 Phone:
Fax:		 203-785-4747
203-737-1077

Yale Interventional Radiology consists of a division of physicians specializing in the use of imaging modalities to guide the performance of minimally invasive diagnostic and therapeutic procedures in numerous parts of the body. Additionally, we are closely allied with Yale Vascular Surgery in a Yale Vascular Center, especially in the evaluation and treatment of arterial and venous blockages and aneurysms, including newer methods for angioplasty, the removal of material causing arterial blockage, and stent-grafts for aneurysms.


Clinical Interests

Other clinical interests include embolization for uterine fibroids, vascular anomalies, and pelvic congestion syndrome and varicoceles; minimally invasive treatment of cancer using embolization (including chemoembolization) and local treatments such as radiofrequency ablation; the management of varicose veins; interventions in bile ducts and the urinary track; and the placement of a variety of venous access devices.

Through the Yale Vascular Malformation Center, we are a world leader in the evaluation and treatment of patients with hereditary hemorrhagic telangiectasia (HHT, or Osler-Weber-Rendu syndrome).

Yale Interventional Radiologists see patients at our office in the Yale Physicians’ Building on Howard Avenue and perform procedures at Yale-New Haven Hospital and at the Veterans Administration Medical Center. In addition, we are active in training residents and fellows and conduct research.


Research Direction

  • Outcome of embolotherapy for pulmonary arteriovenous malformations
  • Transjugular intrahepatic portosystemic shunts
  • Locoregional therapy for hepatocellular carcinoma
  • Outcome after uterine fibroid embolization
  • Carotid artery stenosis
  • Thrombolytic spects and applications
  • CT angiography of peripheral vascular disease
  • Dynamic vascular imaging
  • Clinical applications of phase contrast imaging
  • Hemodialysis access catheters
  • Endovascular surgery
  • Stent technology
  • Vascular imaging: improving vascular outcomes
  • Fenestrated endografts; branched endografts
  • Embolotherapy technics
  • Vascular malformations
  • Male infertility
  • Pelvic congestion syndrome and fibroid disease
  • Hereditary Hemorrhagic Telangiectasia

Yale Interventional Oncology Research Lab

Yale IR offers a unique research environment that encompasses the full gamut of basic, translational and clinical science, including clinical trials. Our NIH-funded science focuses on topics such as drug delivery, novel molecular targeted imaging and therapeutics, artificial intelligence and advanced intra-procedural navigation systems. We collaborate with partners in immunobiology, biomedical engineering and biophysics and have the most advanced experimental imaging equipment at our disposal, including a fully equipped state-of-the art Philips Allura Clarity C-Arm Interventional Suite. Our group has a track record of fostering careers of excellent IR trainees and junior faculty. Previous researchers and physician-scientists in IR won numerous national and international research prizes, such as the RSNA Trainee Prize, SIR Constantine Cope award, ECR Invest in Youth award and the prestigious PEO Foundation Award for Excellent Women in Science. Additional information can be found at the Yale Interventional Oncology Research Lab Website.

Education

Yale IR residency training in the Yale New Haven Medical Center program is the only IR training program in the state of Connecticut. Yale IR residency received continued accreditation from the ACGME in 2019. We offer three IR Internship-Residency positions per year. We are accepting IR Intern-Residency applications through ERAS/NRMP on a yearly basis. For more information about the Yale IR residency program, click here.

Yale IR Global Outreach

Yale IR is a leader in global IR, bringing minimally invasive treatment options to underserved populations worldwide. In collaboration with Emory University and Muhimbili University of Health and Allied Sciences, Yale IR has established the first accredited IR training program in sub-Saharan Africa. Before initiation of this training program there was not a single interventional radiologist in Tanzania, an East African nation with a population of nearly 60 million people. This means that many essential and life-saving procedures could not be performed. Yale IR has coordinated deployment of 14 teams to Tanzania for two-week teaching trips since 2018, overseeing more than 300 IR procedures ranging from simple biopsies to complex vascular procedures. Yale IR recognizes the important role minimally invasive treatments will play in improving medical care in Africa and is committed to making these advances available to as many people as possible. This work is supported by several institutional and national grants, including the RSNA Research & Education Foundation Derek Harwood-Nash International Scholar Grant. For more information visit Yale IR Outreach Program Website and @road2IR on Twitter, Facebook, and Instagram.


Recent Publications

2022

  • Operator Learning Curve for Prostatic Artery Embolization and Its Impact on Outcomes in 296 Patients.Powell T, Rahman S, Staib L, Bhatia S, Ayyagari R. Cardiovasc Intervent Radiol. 2022 Dec 1; 2022 Dec 1. PMID: 36456689.
  • Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?Wang Y, Strazzabosco M, Madoff DC. Curr Oncol Rep. 2022 Dec; 2022 Oct 18. PMID: 36255606.
  • Night Watch: Positive Effect of a Night Float Call System on IR Resident Wellness.Chan SM, Laage Gaupp FM, Green CS, Malpani R, Madoff DC. J Vasc Interv Radiol. 2022 Dec; 2022 Aug 29. PMID: 36049663.
  • Machine Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.Iseke S, Zeevi T, Kucukkaya AS, Raju R, Gross M, Haider SP, Petukhova-Greenstein A, Kuhn TN, Lin M, Nowak M, Cooper K, Thomas E, Weber MA, Madoff DC, Staib L, Batra R, Chapiro J. AJR Am J Roentgenol. 2022 Nov 23; 2022 Nov 23. PMID: 35975886.
  • MRI-based in vivo macrophage imaging to monitor immune response following radiofrequency ablation of the liver.Santana JG, Petukhova-Greenstein A, Gross M, Hyder F, Pekurovsky V, Gottwald LA, Boustani A, Walsh JJ, Kucukkaya AS, Malpani R, Madoff DC, Goldberg SN, Ahmed M, Joshi N, Coman D, Chapiro J. J Vasc Interv Radiol. 2022 Nov 21; 2022 Nov 21. PMID: 36423815.
  • Oncopharmacology in Interventional Radiology.Raja J, Madoff DC. Semin Intervent Radiol. 2022 Aug; 2022 Nov 17. PMID: 36406031.
  • Long-Term Survival After Surgery Versus Ablation for Early Liver Cancer in a Large, Nationally Representative Cohort.Charalel RA, Mushlin AI, Li D, Mao J, Ibrahim S, Carlos RC, Kwan SW, Fortune B, Talenfeld AD, Brown RS Jr, Madoff DC, Johnson MS, Sedrakyan A. J Am Coll Radiol. 2022 Nov; 2022 Oct 5. PMID: 36208842.
  • Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study.Gregory J, Tselikas L, Allimant C, de Baere T, Bargellini I, Bell J, Bilbao JI, Bouvier A, Chapiro J, Chiesa C, Decaens T, Denys A, Duran R, Edeline J, Garin E, Ghelfi J, Helmberger T, Irani F, Lam M, Lewandowski R, Liu D, Loffroy R, Madoff DC, Mastier C, Salem R, Sangro B, Sze D, Vilgrain V, Vouche M, Guiu B, Ronot M. Eur J Nucl Med Mol Imaging. 2022 Oct 25; 2022 Oct 25. PMID: 36282299.
  • Use of a Large-bore Thrombectomy Device for Portal Vein Thrombectomy in the Setting of Prior Transjugular Intrahepatic Portosystemic Shunt Reduction: A Report of 2 Cases.Cornman-Homonoff J, Parmar G, Perez Lozada JC, Marino AG. J Vasc Interv Radiol. 2022 Oct 23; 2022 Oct 23. PMID: 36283594.
  • Transpleural Systemic Artery-to-Pulmonary Artery Shunts: A Potential Mimicker of Pulmonary Arteriovenous Malformations.Fish FA, Chan SM, Pollak J, Schlachter T. J Vasc Interv Radiol. 2022 Oct 23; 2022 Oct 23. PMID: 36283590.
  • Deep Vein Thrombosis: Update on Mechanical Thrombectomy and Intravascular US.Sailer A, Revzin MV, Pollak J, Ayyagari R, Mojibian HR, Nezami N, Pellerito JS, Marino AG. Radiographics. 2022 Oct. PMID: 36190870.
  • Emergency department initiated resuscitative endovascular balloon occlusion of the aorta (REBOA) for out-of-hospital cardiac arrest is feasible and associated with improvements in end-tidal carbon dioxide.Daley J, Buckley R, Kisken KC, Barber D, Ayyagari R, Wira C, Aydin A, Latich I, Lozada JCP, Joseph D, Marino A, Mojibian H, Pollak J, Chaar CO, Bonz J, Belsky J, Coughlin R, Liu R, Sather J, Van Tonder R, Beekman R, Fults E, Johnson A, Moore C. J Am Coll Emerg Physicians Open. 2022 Oct; 2022 Sep 10. PMID: 36176506.
  • Co-limitation towards lower latitudes shapes global forest diversity gradients.Liang J, Gamarra JGP, Picard N, Zhou M, Pijanowski B, Jacobs DF, Reich PB, Crowther TW, Nabuurs GJ, de-Miguel S, Fang J, Woodall CW, Svenning JC, Jucker T, Bastin JF, Wiser SK, Slik F, Hérault B, Alberti G, Keppel G, Hengeveld GM, Ibisch PL, Silva CA, Ter Steege H, Peri PL, Coomes DA, Searle EB, von Gadow K, Jaroszewicz B, Abbasi AO, Abegg M, Yao YCA, Aguirre-Gutiérrez J, Zambrano AMA, Altman J, Alvarez-Dávila E, Álvarez-González JG, Alves LF, Amani BHK, Amani CA, Ammer C, Ilondea BA, Antón-Fernández C, Avitabile V, Aymard GA, Azihou AF, Baard JA, Baker TR, Balazy R, Bastian ML, Batumike R, Bauters M, Beeckman H, Benu NMH, Bitariho R, Boeckx P, Bogaert J, Bongers F, Bouriaud O, Brancalion PHS, Brandl S, Brearley FQ, Briseno-Reyes J, Broadbent EN, Bruelheide H, Bulte E, Catlin AC, Cazzolla Gatti R, César RG, Chen HYH, Chisholm C, Cienciala E, Colletta GD, Corral-Rivas JJ, Cuchietti A, Cuni-Sanchez A, Dar JA, Dayanandan S, de Haulleville T, Decuyper M, Delabye S, Derroire G, DeVries B, Diisi J, Do TV, Dolezal J, Dourdain A, Durrheim GP, Obiang NLE, Ewango CEN, Eyre TJ, Fayle TM, Feunang LFN, Finér L, Fischer M, Fridman J, Frizzera L, de Gasper AL, Gianelle D, Glick HB, Gonzalez-Elizondo MS, Gorenstein L, Habonayo R, Hardy OJ, Harris DJ, Hector A, Hemp A, Herold M, Hillers A, Hubau W, Ibanez T, Imai N, Imani G, Jagodzinski AM, Janecek S, Johannsen VK, Joly CA, Jumbam B, Kabelong BLPR, Kahsay GA, Karminov V, Kartawinata K, Kassi JN, Kearsley E, Kennard DK, Kepfer-Rojas S, Khan ML, Kigomo JN, Kim HS, Klauberg C, Klomberg Y, Korjus H, Kothandaraman S, Kraxner F, Kumar A, Kuswandi R, Lang M, Lawes MJ, Leite RV, Lentner G, Lewis SL, Libalah MB, Lisingo J, López-Serrano PM, Lu H, Lukina NV, Lykke AM, Maicher V, Maitner BS, Marcon E, Marshall AR, Martin EH, Martynenko O, Mbayu FM, Mbuvi MTE, Meave JA, Merow C, Miscicki S, Moreno VS, Morera A, Mukul SA, Müller JC, Murdjoko A, Nava-Miranda MG, Ndive LE, Neldner VJ, Nevenic RV, Nforbelie LN, Ngoh ML, N'Guessan AE, Ngugi MR, Ngute ASK, Njila ENN, Nyako MC, Ochuodho TO, Oleksyn J, Paquette A, Parfenova EI, Park M, Parren M, Parthasarathy N, Pfautsch S, Phillips OL, Piedade MTF, Piotto D, Pollastrini M, Poorter L, Poulsen JR, Poulsen AD, Pretzsch H, Rodeghiero M, Rolim SG, Rovero F, Rutishauser E, Sagheb-Talebi K, Saikia P, Sainge MN, Salas-Eljatib C, Salis A, Schall P, Schepaschenko D, Scherer-Lorenzen M, Schmid B, Schöngart J, Šebeň V, Sellan G, Selvi F, Serra-Diaz JM, Sheil D, Shvidenko AZ, Sist P, Souza AF, Stereńczak KJ, Sullivan MJP, Sundarapandian S, Svoboda M, Swaine MD, Targhetta N, Tchebakova N, Trethowan LA, Tropek R, Mukendi JT, Umunay PM, Usoltsev VA, Vaglio Laurin G, Valentini R, Valladares F, van der Plas F, Vega-Nieva DJ, Verbeeck H, Viana H, Vibrans AC, Vieira SA, Vleminckx J, Waite CE, Wang HF, Wasingya EK, Wekesa C, Westerlund B, Wittmann F, Wortel V, Zawiła-Niedźwiecki T, Zhang C, Zhao X, Zhu J, Zhu X, Zhu ZX, Zo-Bi IC, Hui C. Nat Ecol Evol. 2022 Oct; 2022 Aug 8. PMID: 35941205.
  • An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma.Madoff DC, Abi-Jaoudeh N, Braxton D, Goyal L, Jain D, Odisio BC, Salem R, Schattner M, Sheth R, Li D. Oncologist. 2022 Oct 1. PMID: 35925597.
  • Development of paravertebral pseudoaneurysms following vertebral augmentation: a report of two cases.Nam D, Johnson MH, Mojibian H, Hebert RM, Cornman-Homonoff J. Clin Imaging. 2022 Oct; 2022 Jul 23. PMID: 35914342.

More Publications

Meet Our Faculty
IR on Instagram